Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 696-231-5 | CAS number: 1361000-03-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- calculation (if not (Q)SAR)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- accepted calculation method
- Justification for type of information:
- The calculation of acute toxicity values for 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE is based on the current understanding and knowledge of the test substance. Toxicity data were obtained from publically available publications such as the opinion document from the Scientific Committee on Consumer Safety of the European Commission on 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE, and study reports provided by Service Germany GmbH. If more (detailed) information becomes available or if updated guidance becomes available, the statement might be subject to review
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The calculation of acute toxicity values for 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE is based on the current understanding and knowledge of the test substance. Toxicity data were obtained from publically available publications such as the opinion document from the Scientific Committee on Consumer Safety of the European Commission on 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE, and study reports provided by Service Germany GmbH. If more (detailed) information becomes available or if updated guidance becomes available, the statement might be subject to review
Test material
- Reference substance name:
- 2-hexylpyrazole-3,4-diamine;sulfuric acid
- EC Number:
- 696-231-5
- Cas Number:
- 1361000-03-4
- Molecular formula:
- C9H18N4 x 0.5 H2SO4
- IUPAC Name:
- 2-hexylpyrazole-3,4-diamine;sulfuric acid
- Reference substance name:
- C6 Pyrazole hemisulfate
- IUPAC Name:
- C6 Pyrazole hemisulfate
- Reference substance name:
- 4,5-diamino-1-hexyl-1H-pyrazole hemisulfate
- IUPAC Name:
- 4,5-diamino-1-hexyl-1H-pyrazole hemisulfate
- Test material form:
- solid: crystalline
- Details on test material:
- UNLABELLED TEST SUBSTANCE- Name of test material: 4,5-diamino-1-hexyl-1H-pyrazole hemisulfate (Code: A0021277)- TSIN: WR804146 - Substance type: Pure active substance- Physical state: White feathery crystals- Storage condition of test material: Ambient temperature (in dark)LABELLED TEST SUBSTANCE- Name of test material: [14C] n-Hexylpyrazole Hemisulfate ([14C]-C6P)- Substance type: Pure active substance- Specific activity: 59 mCi/mmol (2.18 GBq/mmol) (measured by mass spectroscopy)- Locations of the label: Ring-14C- Storage condition of test material: At - 20°C.
Constituent 1
Constituent 2
Constituent 3
Results and discussion
Effect levels
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- ca. 218 mg/kg bw
Any other information on results incl. tables
Oral LD50value using data from repeated dose toxicity studies and evaluation of applicability of thein vivoMTD data to meet OECD requirements for acute oral toxicity
The acute oral toxicity of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATEwas not investigated.
However, no deaths were observed in the sub-chronic (13-week) oral toxicity study (Ref 2) or in the developmental toxicity study in rats (Ref 3) at dose levels up to 20 mg/kg bw/day. Likewise, in a 28-day repeated dose range finding study in rats (Ref 4), none of the doses up to 240 mg/kg bw /day caused any deaths. This 28-day dose range finding study for the 90-day study was not carried out as a GLP study and was conducted using the dihydrochloride salt.
Since no additionalin vivostudies are available, a conservative value for the oral acute toxicity (LD50,oral) of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATEwas set at 218 mg/kg bw. This was calculated by applying a conversion factor of 0.91 to the LD50value of 240 mg/kg based on the molar mass differences between the hydrochloride and hemisulfate salt of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE(Ref 1). This derived LD50value is within the required test concentrations and possible LD50estimations, namely between 50 and 300 mg/kg bw for the OECD.
Table 1: Comparison of study requirements from OECD guidelines for acute oral toxicity study(f = female, m = male).
Test type |
Guideline (OECD) |
Animal species |
Doses (mg/kg bw) |
animal number |
observation period |
determined LD50mg/kg bw |
Acute oral toxicity
|
423 (Ref 5) |
Rat |
5, 50, 300, 2000 (Guideline recommendation) |
3/dose (Total: 3 to 12) |
1 to 14 days |
Possible values: 5, 25, 50, 200, 300, 500, 2000, 2500, 5000 |
28-Day repeated dose (Ref 4) |
407 (Ref 6)
Not GLP compliant |
Rat |
Determination of MTD (doses tested: 26, 80, 240) |
(required: min. 3) 10 to 15/dose (m & f) |
28 days |
LD50: >240 (none of the animals died) MTD: >240 |
Result:
LD50 calcoral 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE= 218 mg/kg bw
Conclusion: Based on the above, a conservative value for the LD50of 218 mg/mg/kg bw determined from the 28-day repeated toxicity study was used for the calculations of the acute dermal and inhalation toxicity potential of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE. This LD50, oralvalue is in line with the OECD criteria.
Data from anin vivoADME studies
The oral bioavailability of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATEbased on the blood AUC was high (93%) compared to the AUC after i.v. administration. When calculated from the urine data from the mass balance groups, the oral bioavailability was also determined to be high and was 84% at 12 mg/kg bw (Table 2).
The average dermal absorption of1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE,when calculated from the urine data from the mass balance groups, was low, and was 9% at 11 mg/kg bw (0.5 hours exposure) and 17% at 11.5 mg/kg bw (24 hours exposure).
After i.v. and oral administration, elimination, mainly via the urine, was fast, with 85% of the total amount being excreted within in the first 48 h. The elimination after dermal doses was relatively slow, with 62% and 50% of the absorbed radioactive dose recovered by 48 h after a 0.5 h and 24 h exposure, respectively.
Table 2: Overview of the mass balance data from the ADME study with1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATEin rats
Group No. |
1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATEDose Level / Concentration |
Dosing route |
Absorption (%) |
Excretion via urine/feces (%) (relative to administered dose) |
1 |
11.9 mg/kg bw |
i.v. |
100 |
69 / 12 |
2 |
12 mg/kg bw |
oral |
82 |
69 / 15 |
3 |
11 mg/kg bw; 0.186 mg/cm² (0.5 hours exposure) |
dermal |
9* |
3 / 4 |
4 |
11.5 mg/kg bw; 0.208 mg/cm² (24 hours exposure) |
dermal |
17* |
8 / 6 |
*: Percentage of the dose recovered from: excretion + exhaled air + cage-wash + carcass.
For appropriate comparability between the different application routes, the mass balance data were used in the calculations of inhalation and dermal acute toxicity according to the applicability to the endpoint to derive the most conservative extrapolation.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The acute oral toxicity of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE was determined from a 28-day repeated dose finding study conducted using the dihydrochloride salt. The determined LD50, oral value of 218 mg/kg bw is considered conservative since none of the animals died at this dose and it was 10-fold lower than that of a structurally related chemical. It was also in accordance with the required test concentrations and possible LD50 estimations (between 50 and 300 mg/kg bw) for the OECD. Based on the calculated LD50 oral. value, 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE should be classified as Acute Tox Cat.3; H301: “toxic if swallowed”, according to the Globally Harmonized System of Classification and Labeling (GHS).
- Executive summary:
1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE is a diaminopyrazole and is an ingredient used in oxidative hair coloring products.
Based on the available in vivo repeated dose toxicity study of the dihydrochloride salt (Ref 4), together with a toxicokinetics study of orally and topically applied hemisulfate salt (ADME) (Ref 6), the acute oral toxicity of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE could be determined, as well as its acute dermal and acute inhalation toxic potential.
The pre-clinical toxicity studies were carried out with two forms of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE, namely the hemisulfate salt and the dihydrochloride salt. The free base component is considered responsible for the toxic potential of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE salts. Therefore, studies carried out with the hemisulfate and dihydrochloride salts are both relevant for the risk assessment of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE upon adjustment for molecular weight and content. Correspondingly, in all studies performed with the dihydrochloride salt, the concentrations used were converted to the concentration of the hemisulfate salt by applying a conversion factor of 0.91 adjusting for the differences in molecular weight and free base content (Ref 1).
The acute oral toxicity of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE was not investigated.
However, no deaths were observed at doses up to 240 mg/kg bw /day in a 28-day repeated dose range finding study in rats using the dihydrochloride salt (Ref 3). This value was adjusted using the conversion factor of 0.91 to result in an oral LD50 value of 218 mg/kg for the hemisulfate salt. Since no additional in vivo studies are available, a conservative value for the oral acute toxicity (LD50, oral) of 1-HEXYL-1H-PYRAZOLE-4,5-DIAMINE HEMISULFATE was set at 218 mg/kg bw. This derived LD50 value is within the required test concentrations and possible LD50 estimations for the OECD. The LD50, calc, oral of 218 mg/kg bw was therefore used for the route extrapolation calculations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
